Financials in USD. Standardized financial statements.
A compact view of how Inari Medical, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
| Revenue? | $493.63M | $383.47M | $276.98M | $139.67M | $51.13M | $6.83M |
| Revenue Growth? | +28.7% | +38.4% | +98.3% | +173.2% | +648.7% | 0.0% |
| Cost of Revenue? | $59.07M | $44.51M | $24.76M | $13.11M | $5.91M | $1.28M |
| Gross Profit? | $434.56M | $338.96M | $252.23M | $126.56M | $45.22M | $5.55M |
| Gross Margin? | +88.0% | +88.4% | +91.1% | +90.6% | +88.4% | +81.2% |
| Operating Expenses? | $448.60M | $367.06M | $241.38M | $108.14M | $44.42M | $14.69M |
| Operating Income? | -$14.03M | -$28.10M | $6.67M | $18.42M | $801,494 | -$9.14M |
| EBITDA? | $15.19M | -$18.25M | $15.51M | $16.41M | $358,152 | -$8.98M |
| Income Before Tax | $4.25M | -$26.18M | $10.69M | $13.79M | -$1.19M | -$10.15M |
| Income Tax Expense | $5.88M | $3.08M | $845,000 | $0 | $715,293 | $0 |
| Net Income? | -$1.64M | -$29.27M | $9.84M | $13.79M | -$1.91M | -$10.15M |
| EPS? | $-0.03 | $-0.55 | $0.20 | $0.43 | $-0.04 | $-0.23 |
| Diluted EPS? | $-0.03 | $-0.55 | $0.18 | $0.27 | $-0.04 | $-0.23 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality